INDOUS / NSE / Biotechnology & Drugs
Indo US Bio-Tech
1Y Price Trend
Key Information
Recommendations
Target High205.1
Target Low94
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk52.32
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Transcell Biologics: Pioneering Ethical Innovation In Biotech Outlook India
Indo US Bio-Tech Q4 FY26: Margin Compression and Profit Decline Signal Operational Challenges Markets Mojo
Five Consecutive Losses Push Indo US Bio-Tech Ltd to a New 52-Week Low Markets Mojo
Indo Us Bio-Tech FY26 net profit falls 19.3% to ₹1,312.29 lakh scanx.trade
Indo Us Bio-Tech FY26 Revenue Up 6.36%, Profit Down 19.36% Whalesbook
List of 5,161 AgriTech Startups in India & Market Trends (May 2026) Tracxn
Woman who failed NEET in 2016 now has Ivy League degree, biotech career in US India Today
Q4 results: ITC, Nykaa, LIC, MTNL, Aurobindo Pharma, and 181 more on May 21 Business Standard
© SharekeyX | Rusaka Technologies 2024-2026

